BOSTON, July 18, 2017 /PRNewswire/ -- GreenLight Biosciences, Inc., a biotechnology company producing novel RNA-based productsfor agricultural, healthcare and other applications, today announced that management will present at the BIO World Congress on Industrial Biotechnology at the Palais des Congres in Montreal, Canada. The presentation
The content of the presentation will be available online from the Media page of the Company's website at www.greenlightbio.com.
GreenLight Biosciences, Inc., is a leader in the development and manufacturing of nucleic acid materials for research, agricultural and healthcare applications. GreenLight's Cell-free Bioprocessing platform enables unprecedented precision, low cost and scalability in the production of RNA-based materials, enabling a broad range of products for pest control and other important agricultural applications. GreenLight is a private company backed by a leading syndicate of notable investors.
Media contact: email@example.com
View original content:http://www.prnewswire.com/news-releases/greenlight-biosciences-to-present-at-the-bio-world-congress-on-industrial-biotechnology-300489572.html
SOURCE GreenLight Biosciences, Inc.
Subscribe to our Free Newsletters!
Nocturnal polyuria refers to increased urine output during night, without an associated increase in ...
Nootropics are drugs or substances which improve cognition that are being increasingly used ...
Pterygium or Surfer's eye is described as a proliferative disorder of the ocular surface possibly ...View All